If you've been stable on a dose for 8+ weeks but weight loss has stalled or appetite hasn't adequately decreased, a modest increase may be warrantedor a switch to a dual-compound therapy like GLP-Squared (semaglutide plus tirzepatide)
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
By October 2025, Reuters reported that Mounjaro had become Indias top-selling drug by value, generating about 1 billion in sales that month
Our medical weight loss injection program offers a non-surgical, physician-guided solution to help you achieve and maintain a healthy weight
Figure 1 Signaling pathways involved in macrophage activation in CKD-associated vascular inflammation Macrophages are pivotal contributors to vascular inflammation in CKD, driven by various signaling pathways that regulate their activation